A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Positive Chronic Hbv: Week 48 Efficacy and Safety Results von Chan, H.L.Y, Fung, S, Seto, W.K, Chuang, W.-L, Chen, C.-Y, Kim, H.J, Hui, A.J, Janssen, H.L.A, Chowdhury, A, Tsang, T.Y.O, Mehta, R, Gane, E, Flaherty, J.F, Massetto, B, Kitrinos, K, Dinh, P, Subramanian, G.M, McHutchison, J.G, Lim, Y.-S, Acharya, S.K, Agarwal, K

Volltext

GS12 - A Phase 3 Study of Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate in Patients with Hbeag-Positive Chronic Hbv: Week 48 Efficacy and Safety Results von Chan, H.L.Y., Fung, S., Seto, W.K., Chuang, W.-L., Chen, C.-Y., Kim, H.J., Hui, A.J., Janssen, H.L.A., Chowdhury, A., Tsang, T.Y.O., Mehta, R., Gane, E., Flaherty, J.F., Massetto, B., Kitrinos, K., Dinh, P., Subramanian, G.M., McHutchison, J.G., Lim, Y.-S., Acharya, S.K., Agarwal, K.

Volltext